These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 22103885
1. C-type natriuretic peptide forms in adult hyperthyroidism: correlation with thyroid hormones and markers of bone turnover. Schouten BJ, Prickett TC, Hunt PJ, Richards AM, Geffner ME, Olney RC, Espiner EA. Clin Endocrinol (Oxf); 2012 Jun; 76(6):790-6. PubMed ID: 22103885 [Abstract] [Full Text] [Related]
2. Plasma C-type natriuretic peptide forms and thyroid status in prepubertal children with acquired thyroid disease. Reh CS, Olney RC, Azen C, Prickett TC, Espiner EA, Geffner ME. Clin Endocrinol (Oxf); 2012 Feb; 76(2):228-35. PubMed ID: 21815902 [Abstract] [Full Text] [Related]
3. C-type Natriuretic Peptide: a novel biomarker of steroid induced bone toxicity in children with acute lymphoblastic leukemia (ALL). Prickett TC, Lyver A, Wilson R, Espiner EA, Sullivan MJ. Peptides; 2012 Jul; 36(1):54-9. PubMed ID: 22564489 [Abstract] [Full Text] [Related]
4. Effect of nutrition on plasma C-type natriuretic peptide forms in adult sheep: evidence for enhanced C-type natriuretic peptide degradation during caloric restriction. Prickett TC, Ryan JF, Wellby M, Barrell GK, Yandle TG, Richards AM, Espiner EA. Metabolism; 2010 Jun; 59(6):796-801. PubMed ID: 20005543 [Abstract] [Full Text] [Related]
5. Impact of age, phenotype and cardio-renal function on plasma C-type and B-type natriuretic peptide forms in an adult population. Prickett TC, Olney RC, Cameron VA, Ellis MJ, Richards AM, Espiner EA. Clin Endocrinol (Oxf); 2013 May; 78(5):783-9. PubMed ID: 22963390 [Abstract] [Full Text] [Related]
15. Markers of bone turnover in hyperthyroidism and the effects of treatment. Garnero P, Vassy V, Bertholin A, Riou JP, Delmas PD. J Clin Endocrinol Metab; 1994 Apr; 78(4):955-9. PubMed ID: 8157727 [Abstract] [Full Text] [Related]
16. [Serum osteocalcin and bone turnover in hyperthyroidism]. León Sanz M, Hawkins F, Larrodera L, Sarabia F, Schuller A. Rev Clin Esp; 1990 Mar; 186(4):155-8. PubMed ID: 2367716 [Abstract] [Full Text] [Related]
17. [Serum osteocalcin in hyperthyroidism]. Roiter I, Legovini P, Da Rin G, Galliazzo S, Di Virgilio R, Foscolo G, Breda F, Conte N. Ann Ital Med Int; 1990 Mar; 5(2):95-9. PubMed ID: 2248865 [Abstract] [Full Text] [Related]
18. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women. Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S. J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648 [Abstract] [Full Text] [Related]
19. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. Amato G, Mazziotti G, Sorvillo F, Piscopo M, Lalli E, Biondi B, Iorio S, Molinari A, Giustina A, Carella C. Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617 [Abstract] [Full Text] [Related]
20. Response of plasma CNP forms to acute anabolic and catabolic interventions in growing lambs. Prickett TC, Barrell GK, Wellby M, Yandle TG, Richards AM, Espiner EA. Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1395-400. PubMed ID: 17227962 [Abstract] [Full Text] [Related] Page: [Next] [New Search]